ResMed (RMD) PT Lowered to $290 at KeyBanc
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $215.19 +2.00%
Rating Summary:
11 Buy, 12 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 30 | New: 26
Rating Summary:
11 Buy, 12 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 30 | New: 26
Join SI Premium – FREE
KeyBanc analyst Brett Fishbin lowered the price target on ResMed (NYSE: RMD) to $290.00 (from $302.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
- Black Stone Minerals (BSM) Tops Q2 EPS by 25c
- Keros Therapeutics (KROS) Misses Q2 EPS by 5c
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
KeyBanc, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
